The BBZ combines the expertise of the research groups working in the fields of biotechnology and biomedicine at Leipzig University. It is thanks to these synergies that the Centre for Biotechnology and Biomedicine is a strong force in the national and international life science sector.
Profile
The Centre for Biotechnology and Biomedicine (BBZ) is a Central Institution at Leipzig University and answers directly to the Rectorate. The BBZ is based at BIO CITY LEIPZIG, which was founded in 2003 as part of a biotechnology drive spearheaded by the Free State of Saxony. Here, science and business work together under one roof. Together with other scientific institutions, such as the German Centre for Integrative Biodiversity Research (iDiv), the Max Planck Institute for Evolutionary Anthropology (MPI-EVA) and the Fraunhofer Institute for Cell Therapy and Immunology (IZI), the BBZ forms a science campus on the site of the former Alte Messe in Leipzig.
Tasks
- The BBZ promotes research and development in the fields of biotechnology and biomedicine as well as related disciplines.
- The BBZ promotes cooperation with private enterprises as well as with non-university research institutions. It strives to pool and coordinate the relevant activities in the region, to offer its expertise to a wide range of users, and to support start-ups in this field.
- Curricular teaching tasks are carried out within the faculties that participate in the BBZ, to which the BBZ members belong.
The BBZ should give rise to new courses of study and continuing education and training opportunities.
Guiding Principles and Goals of the BBZ
Cooperation and the shared use of resources form an important basis for implementing the BBZ’s goals:
- Consolidating and developing the high quality of research, innovation and training
- Expanding the biotechnological network as an incubator for innovation and technology transfer in product and application development
- New research approaches for future collaborative proposals in an interdisciplinary context.
Continuous further development and specialisation in microsystems and nanosystems technology and biomaterial sciences should enable new, individual diagnostic and therapeutic approaches in the future. These will serve to develop tailor-made biotechnological and biomedical applications for health and environmental technology, nutritional medicine and the bioeconomy.